Clinical Trials Logo

Clinical Trial Summary

Many cardiac and non-cardiac drugs are associated with TdP that may constitute a significant problem because of sudden cardiac death. This study aims to present a comprehensive overview and disproportionality analysis of TdP cases reported to the Food and Drug Administration Adverse Event Reporting System (FAERS) in order to identify new signals of TdP.


Clinical Trial Description

Drug-induced Torsade de Pointes (TdP) is a serious but an overlooked adverse drug reaction because a wide range of marketed drugs associated with TdP are commonly prescribed in routine practice. Owing to the heightened concern of a vast number of drug-TdP associations including newly approved drugs, the investigators, therefore, aims to investigate drug-TdP associations by performing disproportionality analysis in order to identify new signals of TdP utilizing the individual case reports of TdP in the FAERS database. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04293432
Study type Observational [Patient Registry]
Source University of Peshawar
Contact
Status Completed
Phase
Start date May 15, 2019
Completion date January 1, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT04336644 - Continuous Versus Intermittent cARdiac Electrical moNitorinG N/A
Not yet recruiting NCT04437901 - COVIDAR - Arrhythmias in COVID-19